BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6143752)

  • 41. Use of tiazofurin to enhance the metabolism and cytotoxic activities of analogues of guanine, guanosine, and deoxyguanosine.
    Saunders PP; Tan MT; Spindler CD; Robins RK
    Cancer Res; 1987 Feb; 47(4):1022-6. PubMed ID: 3802087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
    Boritzki TJ; Berry DA; Besserer JA; Cook PD; Fry DW; Leopold WR; Jackson RC
    Biochem Pharmacol; 1985 Apr; 34(7):1109-14. PubMed ID: 3985993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
    Balzarini J; De Clercq E
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
    Natsumeda Y; Ikegami T; Olah E; Weber G
    Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purine metabolism of human glioblastoma in vivo.
    Pillwein K; Chiba P; Knoflach A; Czermak B; Schuchter K; Gersdorf E; Ausserer B; Murr C; Goebl R; Stockhammer G
    Cancer Res; 1990 Mar; 50(5):1576-9. PubMed ID: 2154328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A role for guanine ribonucleotides in the regulation of myeloid cell maturation.
    Wright DG
    Blood; 1987 Jan; 69(1):334-7. PubMed ID: 2878694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recovery of the activities of IMP dehydrogenase and GMP synthase after treatment with tiazofurin and acivicin in hepatoma cells in vitro.
    Ikegami T; Natsumeda Y; Weber G
    Adv Exp Med Biol; 1989; 253B():299-304. PubMed ID: 2575350
    [No Abstract]   [Full Text] [Related]  

  • 49. Tiazofurin decreases Ras-GTP complex in K562 cells.
    Hata Y; Natsumeda Y; Weber G
    Oncol Res; 1993; 5(4-5):161-4. PubMed ID: 8305741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
    Szekeres T; Schuchter K; Chiba P; Ressmann G; Lhotka C; Gharehbaghi K; Szalay SM; Pillwein K
    Biochem Pharmacol; 1993 Dec; 46(11):1903-7. PubMed ID: 7903533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.
    Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA
    Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of the signal transduction program by drugs.
    Weber G; Shen F; Prajda N; Yang H; Li W; Yeh A; Csokay B; Olah E; Look KY
    Adv Enzyme Regul; 1997; 37():35-55. PubMed ID: 9381980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus.
    Balzarini J; Lee CK; Herdewijn P; De Clercq E
    J Biol Chem; 1991 Nov; 266(32):21509-14. PubMed ID: 1939181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Critical issues in chemotherapy with tiazofurin.
    Weber G
    Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of purine and tiazofurin metabolism in drug sensitive human chronic myelogenous leukemia K 562 cells.
    Pillwein K; Jayaram HN; Weber G
    Blut; 1988 Aug; 57(2):97-100. PubMed ID: 3165681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of GTP biosynthesis.
    Weber G; Nakamura H; Natsumeda Y; Szekeres T; Nagai M
    Adv Enzyme Regul; 1992; 32():57-69. PubMed ID: 1353938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase.
    Fridland A; Connelly MC; Robbins TJ
    Cancer Res; 1986 Feb; 46(2):532-7. PubMed ID: 3000575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative in vitro studies of Tiazofurin and a selenazole analog.
    Streeter DG; Robins RK
    Biochem Biophys Res Commun; 1983 Sep; 115(2):544-50. PubMed ID: 6138036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells.
    Vitale M; Zamai L; Falcieri E; Zauli G; Gobbi P; Santi S; Cinti C; Weber G
    Cytometry; 1997 Feb; 30(1):61-6. PubMed ID: 9056744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tiazofurin and selenazofurin induce depression of cGMP and phosphatidylinositol pathway in L1210 leukemia cells.
    Parandoosh Z; Robins RK; Belei M; Rubalcava B
    Biochem Biophys Res Commun; 1989 Oct; 164(2):869-74. PubMed ID: 2554903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.